These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8331558

  • 1. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
    Mizumoto H, Karasawa A, Kubo K.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):200-6. PubMed ID: 8331558
    [Abstract] [Full Text] [Related]

  • 2. Effects of adenosine A1-agonist and -antagonist on urinary volume and Na excretion in IAP-treated and non-treated rats.
    Mizumoto H, Karasawa A.
    Jpn J Pharmacol; 1993 Oct; 63(2):257-9. PubMed ID: 8283837
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a novel adenosine A1 receptor antagonist, in conscious dogs.
    Kobayashi T, Mizumoto H, Karasawa A.
    Biol Pharm Bull; 1993 Dec; 16(12):1231-5. PubMed ID: 8130772
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions.
    Kusaka H, Karasawa A.
    Jpn J Pharmacol; 1993 Dec; 63(4):513-9. PubMed ID: 8121084
    [Abstract] [Full Text] [Related]

  • 11. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
    Levens N, Beil M, Jarvis M.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
    [Abstract] [Full Text] [Related]

  • 12. Pertussis toxin unmasks stimulatory myocardial A2-adenosine receptors on ventricular cardiomyocytes.
    Stein B, Mende U, Neumann J, Schmitz W, Scholz H.
    J Mol Cell Cardiol; 1993 Jun; 25(6):655-9. PubMed ID: 8411191
    [Abstract] [Full Text] [Related]

  • 13. The effects of adenosine on water and sodium excretion.
    Yagil Y.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):826-35. PubMed ID: 8113995
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in various models of acute renal failure in rats.
    Yao K, Kusaka H, Sano J, Sato K, Karasawa A.
    Jpn J Pharmacol; 1994 Apr; 64(4):281-8. PubMed ID: 8057529
    [Abstract] [Full Text] [Related]

  • 17. Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.
    Suzuki F, Shimada J, Mizumoto H, Karasawa A, Kubo K, Nonaka H, Ishii A, Kawakita T.
    J Med Chem; 1992 Aug 07; 35(16):3066-75. PubMed ID: 1501234
    [Abstract] [Full Text] [Related]

  • 18. Effects of KW-3902, a novel adenosine A1-receptor antagonist, on cephaloridine-induced acute renal failure in rats.
    Nagashima K, Kusaka H, Sato K, Karasawa A.
    Jpn J Pharmacol; 1994 Jan 07; 64(1):9-17. PubMed ID: 8164396
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
    Wise A, Sheehan M, Rees S, Lee M, Milligan G.
    Biochemistry; 1999 Feb 23; 38(8):2272-8. PubMed ID: 10029519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.